Importance Combining 2 first-line treatments for erectile dysfunction (ED) or initiating other
modalities in addition to a first-line therapy may produce beneficial outcomes. Objective To …

CONTEXT: Erectile dysfunction (ED) after radical prostatectomy (RP) has a significant
negative impact on a patient's health-related quality of life. Phosphodiesterase type 5 …

Radical prostatectomy (RP) represents one of the most commonly used first-line treatment
modalities in men with localized prostate cancer. One of the most feared post-surgical …

The pathophysiology of erectile dysfunction after radical prostatectomy (RP) is believed to
include neuropraxia, which leads to temporarily reduced oxygenation and subsequent …

Vacuum therapy (VT) utilizes negative pressure to distend the corporal sinusoids and to
increase the blood inflow to the penis. Depending on its purpose, VT could be used as …

Many therapies for erectile dysfunction (ED) after prostate cancer treatment improve erectile
firmness, yet, most couples stop using aids within 1–2 years. Patients and partners who …

Study Type–Therapy (outcomes research) Level of Evidence 2b What's known on the
subject? and What does the study add? Intracavernosal injection (ICI) therapy is an …

Radical prostatectomy (RP) remains the standard treatment for men with clinically localized
prostate cancer, despite the range of alternative treatment modalities. Even with significant …

Introduction Postprostatectomy erectile dysfunction (ED) remains a serious quality-of-life
issue. Recent advances in the understanding of the mechanism of postprostatectomy ED …

Introduction: Erectile dysfunction (ED) affects over 150 million men worldwide. Oral
phosphodiesterase-5 (PDE5) inhibitors are currently used as a first-line therapy and a …